Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Iain McGill joins EUSA Pharma

This article was originally published in Scrip

Executive Summary

EUSA Pharma (UK/US), a speciality pharmaceutical company focused on oncology, pain control and critical care, has named Iain McGill president, Europe and International. The appointment marks the completion of EUSA's executive management team and the company’s commercial infrastructure. Mr McGill joins from Wyeth Pharmaceuticals, where he was vice-president and global manager for the company’s transplantation business. Previously, he was the head of Novartis’s transplantation, immunology and infectious diseases business unit in Canada, and was a global brand director at Novartis’s headquarters in Switzerland.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts